pharma · Chronic Kidney Disease Requiring Chronic Dialysis · UNCY
Unicycive Therapeutics
Unicycive Therapeutics patent portfolio — 4 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Los Altos, USA HQ
2016 Founded
23 Employees
Public company Type
UNCY · NYSE Ticker
Company details
- Status
- Public
- HQ
- Los Altos, USA
- Founded
- 2016
- Employees
- 23
- Programs
- 1
- Drugs
- 3
- Patents
- 4
Unicycive Therapeutics patents
4 pharmaceutical patents indexed for Unicycive Therapeutics. 0 expire within 24 months.
Unicycive Therapeutics has 4 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
Frequently asked questions
How many patents does Unicycive Therapeutics have?
4 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Unicycive Therapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.